CN110483376B - Synthesis method of intermediate N-phenyl-4-piperidone - Google Patents
Synthesis method of intermediate N-phenyl-4-piperidone Download PDFInfo
- Publication number
- CN110483376B CN110483376B CN201910859031.5A CN201910859031A CN110483376B CN 110483376 B CN110483376 B CN 110483376B CN 201910859031 A CN201910859031 A CN 201910859031A CN 110483376 B CN110483376 B CN 110483376B
- Authority
- CN
- China
- Prior art keywords
- phenyl
- piperidone
- piperidinol
- stirring
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/10—Magnesium; Oxides or hydroxides thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910859031.5A CN110483376B (en) | 2019-09-11 | 2019-09-11 | Synthesis method of intermediate N-phenyl-4-piperidone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910859031.5A CN110483376B (en) | 2019-09-11 | 2019-09-11 | Synthesis method of intermediate N-phenyl-4-piperidone |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110483376A CN110483376A (en) | 2019-11-22 |
CN110483376B true CN110483376B (en) | 2020-11-03 |
Family
ID=68557552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910859031.5A Active CN110483376B (en) | 2019-09-11 | 2019-09-11 | Synthesis method of intermediate N-phenyl-4-piperidone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110483376B (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1999067219A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
WO1999066934A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
CN101638378A (en) * | 2009-06-25 | 2010-02-03 | 浙江汇能动物药品有限公司 | Synthetic method of N-alkyl substituted-3-piperidones |
CN106008552A (en) * | 2015-03-01 | 2016-10-12 | 南京圣和药业股份有限公司 | Benzo[e]pyrazolo[1, 5-c][1, 3]oxazine compound and application thereof |
CN106432058A (en) * | 2016-09-17 | 2017-02-22 | 青岛云天生物技术有限公司 | Preparation method of Niraparib intermediate 4-(3S-piperidine-3-yl)aniline |
CN108203404A (en) * | 2018-03-02 | 2018-06-26 | 上海博邦医药科技有限公司 | (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani |
-
2019
- 2019-09-11 CN CN201910859031.5A patent/CN110483376B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1999067219A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
WO1999066934A1 (en) * | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS |
CN101638378A (en) * | 2009-06-25 | 2010-02-03 | 浙江汇能动物药品有限公司 | Synthetic method of N-alkyl substituted-3-piperidones |
CN106008552A (en) * | 2015-03-01 | 2016-10-12 | 南京圣和药业股份有限公司 | Benzo[e]pyrazolo[1, 5-c][1, 3]oxazine compound and application thereof |
CN106432058A (en) * | 2016-09-17 | 2017-02-22 | 青岛云天生物技术有限公司 | Preparation method of Niraparib intermediate 4-(3S-piperidine-3-yl)aniline |
CN108203404A (en) * | 2018-03-02 | 2018-06-26 | 上海博邦医药科技有限公司 | (R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani |
Also Published As
Publication number | Publication date |
---|---|
CN110483376A (en) | 2019-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102924424B (en) | Method for synthesizing doxepin hydrochloride | |
CN101891621A (en) | Compounding method for 3- ethyoxyl-4-ethoxycarbonyl phenylacetic acid | |
CN104478790A (en) | Preparation method of S-type apremilast | |
CN110483376B (en) | Synthesis method of intermediate N-phenyl-4-piperidone | |
CN103694167A (en) | Method for synthesizing flunixin meglumine | |
CN104876883B (en) | The synthetic method of anti-insomnia medicine Su Woleisheng intermediates | |
CN102924362B (en) | Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride | |
CN108059610A (en) | A kind of preparation method of three ketene compound of 3- acyl groups loop coil | |
CN111072498A (en) | Preparation method of chemical intermediate N-isopropyl-para-fluoroaniline | |
CN102702063B (en) | Method for preparing levetiracetam | |
CN101367715B (en) | Synthesis of substituted methyl benzylketone | |
CN111320591B (en) | Method for synthesizing chiral gamma-amino alcohol | |
CN111574528B (en) | Method for preparing medical intermediate pyranoquinoline derivative | |
CN104672180B (en) | Chiral preparation method of [(1S)-3-methyl-1-[[(2R)-2-methylepoxyethyl]carbonyl]butyl]tert-butyl carbamate | |
CN107311911A (en) | A kind of preparation method of Ni Lapani chiral intermediate | |
CN107501136B (en) | A method of it prepares together with diaryl methylamines | |
CN102875275B (en) | Method for preparing aryl nitrile by aryl halogenide | |
CN101148402A (en) | Process for preparing 2-bromofluorenone | |
CN104496829A (en) | New crystal form of dapoxetine hydrochloride as well as preparation method and application thereof | |
CN110483375A (en) | A kind of synthetic method of intermediate 4- piperidones | |
CN105968019A (en) | Preparation method of chloroprocaine hydrochloride | |
CN117304076B (en) | Preparation method of N-sulfonyl amidine compound | |
CN104402695B (en) | One pot process m-hydroxy acetophenone | |
CN104292133A (en) | Method for synthesizing anti-cancer drug vorinostat | |
JPH0737442B2 (en) | Benzylselenobenzamides obtained from anilines and benzylamines, and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Jin Yueshuang Inventor after: Tang Yiqiang Inventor after: Lu Xuelei Inventor after: Li Shufeng Inventor after: Chen Jianjiang Inventor before: Chen Jianjiang |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201010 Address after: No. 146, Fenyuan street, Xinzhou Development Zone, Shanxi Province Applicant after: Shanxi Zhichuang Pharmaceutical Research Technology Co., Ltd Address before: 317500 418 Dian Dian Cun, New River Town, Wenling City, Taizhou, Zhejiang Applicant before: Chen Jianjiang |
|
GR01 | Patent grant | ||
GR01 | Patent grant |